{"name": "Entra Pharmaceuticals",
 "permalink": "entra-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/entra-pharmaceuticals",
 "homepage_url": "http://www.entrapharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@entrapharma.com",
 "phone_number": "617-358-4927",
 "description": "",
 "created_at": "Tue Jun 16 02:52:12 UTC 2009",
 "updated_at": "Wed Apr 03 15:20:48 UTC 2013",
 "overview": "\u003Cp\u003ESpringLeaf Therapeutics, Inc. was formerly known as Entra Pharmaceuticals, Inc. and changed its name to SpringLeaf Therapeutics, Inc. in March 2011. The company was incorporated in 2007 and is based in Boston, Massachusetts.\u003C/p\u003E\n\n\u003Cp\u003ESpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf\u0026#8217;s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       36],
      "assets/images/resized/0004/8730/48730v1-max-150x150.jpg"],
     [[250,
       61],
      "assets/images/resized/0004/8730/48730v1-max-250x250.jpg"],
     [[450,
       110],
      "assets/images/resized/0004/8730/48730v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Co-founder",
    "person":
     {"first_name": "Michael",
      "last_name": "Cima",
      "permalink": "michael-cima",
      "image":
       {"available_sizes":
         [[[100,
            150],
           "assets/images/resized/0025/1815/251815v1-max-150x150.jpg"],
          [[150,
            225],
           "assets/images/resized/0025/1815/251815v1-max-250x250.jpg"],
          [[150,
            225],
           "assets/images/resized/0025/1815/251815v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Director",
    "person":
     {"first_name": "Michael",
      "last_name": "A. Greeley",
      "permalink": "michael-a-greeley",
      "image":
       {"available_sizes":
         [[[100,
            150],
           "assets/images/resized/0010/8676/108676v2-max-150x150.jpg"],
          [[166,
            250],
           "assets/images/resized/0010/8676/108676v2-max-250x250.jpg"],
          [[300,
            450],
           "assets/images/resized/0010/8676/108676v2-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$4.2M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.xconomy.com/boston/2008/12/18/entra-pharma-raises-42m/",
    "source_description": "Entra Pharma Raises $4.2M",
    "raised_amount": 4200000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 12,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Flybridge Capital Partners",
         "permalink": "flybridge-capital",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0002/3209/23209v2-max-150x150.jpg"],
             [[229,
               82],
              "assets/images/resized/0002/3209/23209v2-max-250x250.jpg"],
             [[229,
               82],
              "assets/images/resized/0002/3209/23209v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "North Bridge Venture Partners",
         "permalink": "north-bridge-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0001/0794/10794v1-max-150x150.png"],
             [[250,
               70],
              "assets/images/resized/0001/0794/10794v1-max-250x250.png"],
             [[257,
               72],
              "assets/images/resized/0001/0794/10794v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "8 St. Mary's Street, Suite 601",
    "address2": "",
    "zip_code": "02215",
    "city": "Boston",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": 42.3488891,
    "longitude": -71.1068046}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}